Drug Safety Warnings and Updates: July-September 2017

Teresa Rubio, PharmD

Disclosures

January 03, 2018

Editorial Collaboration

Medscape &

In This Article

Ethinyl estradiol; levonorgestrel (LoSeasonique®)

For more on this Drug Safety Labeling Change, click here.

For full prescribing information, click here.

Updated Boxed Warning

Do not prescribe LoSeasonique to women who are known to have the following conditions:

  • Use of hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....